Impact of age, sex and medical history on adverse reactions to the first and second dose of BNT162b2 mRNA COVID-19 vaccine in Japan: a cross-sectional study.

Urakawa, Ryuta; Isomura, Emiko Tanaka; Matsunaga, Kazuhide; Kubota, Kazumi; Ike, Miho

Urakawa, Ryuta; Isomura, Emiko Tanaka; Matsunaga, Kazuhide; Kubota, Kazumi; Ike, Miho.

Affiliation

Urakawa R; Department of Pharmacy, Osaka University Dental Hospital, 1-8 Yamada-oka, Suita, Osaka, 565-0871, Japan. urakawa-r@office.osaka-u.ac.jp.
Isomura ET; Department of Clinical Pharmacy Research and Education, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamada-oka, Suita, Osaka, 565-0871, Japan. urakawa-r@office.osaka-u.ac.jp.
Matsunaga K; First Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Osaka University, 1-8 Yamada-oka, Suita, Osaka, 565-0871, Japan.
Kubota K; Second Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Osaka University, 1-8 Yamada-oka, Suita, Osaka, 565-0871, Japan.
Ike M; Department of Healthcare Information Management, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

BMC Infect Dis ; 22(1): 179, 2022 Feb 23.

Article in En | MEDLINE | ID: mdl-35197017

Subject(s)

COVID-19 Vaccines; COVID-19; Aged; BNT162 Vaccine; Cross-Sectional Studies; Female; Humans; Japan/epidemiology; Male; RNA, Messenger/genetics; SARS-CoV-2

Key words

Adverse effect; COVID-19; Correlation; SARS-CoV-2; Vaccination

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: BMC Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google